查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医疗器械再加工市场按类型(再加工医疗器械),器械类别(关键/半关键/非关键器械),应用(心臟病学,妇科,胃肠病学,麻醉学)2027预测
市场调查报告书
商品编码
1109071

全球医疗器械再加工市场按类型(再加工医疗器械),器械类别(关键/半关键/非关键器械),应用(心臟病学,妇科,胃肠病学,麻醉学)2027预测

Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 173 Pages | 订单完成后即时交付

价格
简介目录

全球医疗器械再加工市场预计将在 2027 年达到 39 亿美元，高于 2022 年的 20 亿美元，预测期内的复合年增长率为 13.7%。

市场增长的主要驱动力是降低医院成本的日益增长的需求、人口老龄化以及对重复使用一次性再加工医疗设备的有利监管批准。然而，进入医疗器械再加工市场必须遵循严格的监管程序，这可能对市场增长构成威胁。

按类型划分，翻新支持和服务部门将在 2021 年占据最大市场份额

按类型，医疗器械再加工市场分为再加工支持与服务和再生医疗器械。 2021 年，后处理支持和服务部门将占最大份额，这主要是由于越来越需要实施减少医疗废物的战略。

按设备类型，关键设备部分在医疗设备再处理市场中占有最大份额

医疗设备再加工市场按设备类型分为关键设备、半关键设备和非关键设备。到 2021 年，关键设备领域将占据该市场的最大份额。该部分的增长主要是由于心臟手术和电生理程序中再加工医疗设备的使用增加。

通过应用，预计心脏病学部门在预测期内的复合年增长率最高

按应用，医疗器械再加工市场细分为心脏病学、胃肠病学、妇科、关节镜和骨科、普通外科和麻醉学以及其他用途(泌尿科、无创手术、患者监测)。预计心脏病学部分将在预测期内实现最高增长。这是由于心血管疾病的患病率增加以及使用大量再加工心臟导管和其他设备的心臟手术数量增加。

到 2021 年，北美将占据医疗器械再加工市场的最大份额

到 2021 年，北美将占据医疗器械再加工市场的最大份额。美国降低医疗成本的需求日益增长以及美国地区一流医疗器械再加工服务提供商的存在等因素预计将有助于北美医疗器械再加工市场的增长。

内容

第一章介绍

第二章研究方法

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 简介
  • 市场动态
    • 驱动程序
    • 约束因素
    • 机会
    • 任务
  • 主要会议和活动
  • 行业趋势
  • 波特五力分析
  • 监管机构、政府机构和其他组织
  • 监管分析
  • 技术分析
  • 供应链分析
  • 生态系统分析
  • 医疗器械再加工市场：专利分析
  • COVID-19 对医疗器械再加工市场的影响

第 6 章按类型：医疗器械再加工市场

  • 简介
  • 回收支持服务
  • 再生医疗设备

第 7 章。按设备类型划分的医疗设备再加工市场

  • 简介
  • 关键设备
  • 半关键设备
  • 非关键设备

第 8 章按应用：医疗器械再加工市场

  • 简介
  • 心内科
  • 消化科学
  • 关节镜和骨科
  • 妇科
  • 普通外科
  • 其他

第 9 章按地区划分：医疗器械再加工市场

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 澳大利亚
    • 日本
    • 中国
    • 印度
    • 其他亚太地区
  • 拉丁美洲
  • 中东和非洲

第 10 章竞争格局

  • 概览
  • 大公司/有影响力公司的战略
  • 主要公司的收入份额分析
  • 2021 年市场份额分析
  • 竞争基准
  • 公司足迹
  • 企业评估象限
  • 竞争场景

第 11 章公司简介

  • 主要公司
    • STRYKER CORPORATION
    • JOHNSON & JOHNSON
    • MEDTRONIC PLC
    • STERIS HEALTHCARE
    • CARDINAL HEALTH(SUSTAINABLE TECHNOLOGIES)
    • ARJO GROUP(RENU MEDICAL, INC.)
    • VANGUARD AG
    • MEDLINE RENEWAL
    • INNOVATIVE HEALTH
    • STERIPRO CANADA, INC
    • NORTHEAST SCIENTIFIC, INC.
  • 其他企业
    • SURETEK MEDICAL
    • KONOIKE GROUP
    • AVANTE HEALTH SOLUTIONS
    • MEDSALV
    • VITRUVIA MEDICAL AG

第12章 附录

简介目录
Product Code: MD 5361

The medical device reprocessing market is projected to reach USD 3.9 billion by 2027 from USD 2.0 billion in 2022, at a CAGR of 13.7% during the forecast period. Growth in the market is mainly driven by the growing need to minimize hospital costs and the rising geriatric population, and the favourable regulatory approvals for reuse of single-use reprocessed medical devices. However, the requirement to follow stringent regulatory procedures to enter the medical device reprocessing market may pose a threat to the market growth.

Based on type, the reprocessing support & services segment holds the largest market share in 2021

Based on type, the medical device reprocessing market is segmented into reprocessing support & services and reprocessed medical devices. In 2021, the reprocessing support & services segment accounted for the largest share of this market, primarily due to the growing need implement strategies to reduce medical wastes.

Based on device type , critical devices segment accounted for the largest share of the medical device reprocessing market

Based on the device type, the medical device reprocessing market is segmented into critical devices, semi-critical devices, and non-critical devices. In 2021, the critical devices segment accounted for the largest share of this market. The growth of this segment is mainly attributed to the increased utilization of reprocessed medical devices for cardiac surgeries and electrophysiology procedures.

Based on application, cardiology segment is expected to have the highest CAGR during the forecast period

Based on application, the medical device reprocessing market is segmented into cardiology, gastroenterology, gynecology, arthroscopy and orthopedic surgery, general surgery & anesthesia, and other applications (urology, non-invasive surgeries, and patient monitoring). The cardiology segment is expected to register the highest growth during the forecast period. This can be attributed to the increasing prevalence of cardiovascular diseases as well as the increasing number of cardiac procedures, which utilizes a large volume of reprocessed cardiology catheters and other equipments.

North America accounted for the largest share of the medical device reprocessing market in 2021

North America accounted for the largest share of the medical device reprocessing market in 2021. Factors such as the increasing need to reduce the healthcare costs in US, and the presence of top medical device reprocessing service providers in the US region are expected to contribute to the growth of the medical device reprocessing market in North America.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
  • By Designation - C-level-35%, Director-level-25%, Others-40%
  • By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%

Key players in the Medical Device Reprocessing Market

The key players operating in the medical device reprocessing market include Stryker Corporation (US), Johnson & Johnson (US), Vanguard AG (Germany), Medtronic PLC (Ireland), Steris Healthcare (US), Medline ReNewal (US), Innovative Health (US), Arjo Group (ReNu Medical, Inc.) (Sweden), SteriPro Canada, INC. (Canada), Northeast Scientific, INC. (US), Cardinal Health (Sustainable Technologies) (US), SureTek Medical (US), Konoike Group (Japan), Avante Health Solutions (US), Medsalv (New Zealand), and Vitruvia Medical AG (Switzerland).

Research Coverage:

The report analyzes the medical device reprocessing market aims at estimating the market size and future growth potential of this market based on various segments such as type, device type, application, and region. The report also includes a service portfolio matrix of various medical device reprocessing services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on service portfolios offered by the top players in the global medical device reprocessing market. The report analyzes this market by type, device type, and application.
  • Service Enhancement/FDA Approvals: Detailed insights on upcoming trends and service approvals in the global medical device reprocessing market
  • Market Development: Comprehensive information on the lucrative emerging markets by type, device type, and application.
  • Market Diversification: Exhaustive information about new services, growing geographies, recent developments, and investments in the global medical device reprocessing market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, competitive leadership mapping, and capabilities of leading players in the global medical device reprocessing market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION AND SCOPE
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 MEDICAL DEVICE REPROCESSING MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY CONSIDERED
    • TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2021
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • FIGURE 2 MEDICAL DEVICE REPROCESSING MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Insights from primary experts
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 8 TOP-DOWN APPROACH
    • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 10 CAGR PROJECTIONS
  • 2.4 DATA TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE REPROCESSING MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 12 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE REPROCESSING MARKET

4 PREMIUM INSIGHTS

  • 4.1 BRIEF OVERVIEW OF MEDICAL DEVICE REPROCESSING MARKET
    • FIGURE 16 INCREASING NEED TO MINIMIZE MEDICAL WASTE AND REDUCE HEALTHCARE COSTS TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE AND COUNTRY (2021)
    • FIGURE 17 AUSTRALIA TO DOMINATE ASIA PACIFIC MEDICAL DEVICE REPROCESSING MARKET DURING FORECAST PERIOD
  • 4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (2020-2027)
    • FIGURE 19 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.5 MEDICAL DEVICE REPROCESSING MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 MEDICAL DEVICE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing level of supply chain cost savings in healthcare facilities
      • 5.2.1.2 Growing adoption of strategies for sustainability and environmental safety
    • TABLE 3 EXAMPLES OF MARKET PLAYERS PROVIDING SUSTAINABILITY THROUGH REPROCESSING
      • 5.2.1.3 Rising geriatric population
    • FIGURE 22 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION
    • TABLE 4 IMPACT ANALYSIS: MARKET DRIVERS
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing risk of hospital-acquired infections among patients
      • 5.2.2.2 Increasing number of medical device surface alterations due to reprocessing
    • TABLE 5 IMPACT ANALYSIS: RESTRAINTS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Regulatory changes favoring adoption of medical device reprocessing
      • 5.2.3.2 Growing opportunities and favorable regulations in developing countries
    • TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory procedures for reprocessed medical devices
    • TABLE 7 IMPACT ANALYSIS: CHALLENGES
  • 5.3 KEY CONFERENCES AND EVENTS
    • TABLE 8 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 EXPANDING SERVICE PORTFOLIO AND MARKET REACH THROUGH ACQUISITIONS
    • TABLE 9 MAJOR ACQUISITIONS IN MEDICAL DEVICE REPROCESSING MARKET
    • 5.4.2 SPECIALTY REPROCESSING
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 10 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT FROM NEW ENTRANTS
    • 5.5.2 THREAT FROM SUBSTITUTES
    • 5.5.3 BARGAINING POWER OF SUPPLIERS
    • 5.5.4 BARGAINING POWER OF BUYERS
    • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 REGULATORY ANALYSIS
    • 5.7.1 NORTH AMERICA
      • 5.7.1.1 US
    • FIGURE 23 PREMARKET NOTIFICATION: 510 (K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
      • 5.7.1.2 Canada
    • 5.7.2 EUROPE
    • TABLE 12 EU COUNTRIES AND THEIR TERRITORY LAWS THAT AUTHORIZE SINGLE-USE DEVICE REPROCESSING
    • 5.7.3 ASIA PACIFIC
      • 5.7.3.1 Japan
      • 5.7.3.2 Australia
      • 5.7.3.3 Rest of Asia Pacific
    • TABLE 13 INTERNATIONAL STANDARDS FOR MEDICAL DEVICE REPROCESSING
  • 5.8 TECHNOLOGY ANALYSIS
    • TABLE 14 TECHNOLOGY AND INNOVATION IN MEDICAL DEVICE REPROCESSING MARKET
  • 5.9 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 SUPPLY CHAIN: MEDICAL DEVICE REPROCESSING MARKET
  • 5.10 ECOSYSTEM ANALYSIS
    • FIGURE 25 MEDICAL DEVICE REPROCESSING MARKET: ECOSYSTEM ANALYSIS
  • 5.11 MEDICAL DEVICE REPROCESSING MARKET: PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE REPROCESSING
    • FIGURE 26 PATENT PUBLICATION TRENDS (2011-JULY 2022)
    • 5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL DEVICE REPROCESSING (JANUARY 2011-JULY 2022)
    • FIGURE 28 TOP APPLICANT JURISDICTIONS FOR MEDICAL DEVICE REPROCESSING PATENTS (JANUARY 2011-JULY 2022)
    • TABLE 15 LIST OF PATENTS/PATENT APPLICATIONS IN MEDICAL DEVICE REPROCESSING MARKET, 2021-2022
  • 5.12 IMPACT OF COVID-19 ON MEDICAL DEVICE REPROCESSING MARKET

6 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 16 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 6.2 REPROCESSING SUPPORT AND SERVICES
    • 6.2.1 REDUCING IN-HOUSE REPROCESSING COSTS AND INCREASING REGULATORY MANDATES TO DRIVE MARKET
    • TABLE 17 REPROCESSING SUPPORT AND SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 REPROCESSED MEDICAL DEVICES
    • 6.3.1 INCREASING ADOPTION OF REPROCESSED DEVICES AT LOWER COSTS TO DRIVE MARKET
    • TABLE 18 REPROCESSED MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS
    • TABLE 19 REPROCESSED MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE

  • 7.1 INTRODUCTION
    • TABLE 20 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
  • 7.2 CRITICAL DEVICES
    • 7.2.1 HIGH COST OF BUYING NEW DEVICES TO DRIVE MARKET
    • TABLE 21 REPROCESSED CRITICAL MEDICAL DEVICE CATEGORY
    • TABLE 22 CRITICAL DEVICES REPROCESSING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 SEMI-CRITICAL DEVICES
    • 7.3.1 INCREASED CASES OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
    • TABLE 23 SEMI-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.4 NON-CRITICAL DEVICES
    • 7.4.1 INCREASING MEDICAL PROCEDURES AND SURGERIES TO DRIVE MARKET
    • TABLE 24 NON-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 25 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 8.2 CARDIOLOGY
    • 8.2.1 RISING CORONARY ARTERY DISEASE CASES TO PROPEL MARKET
    • TABLE 26 MEDICAL DEVICE REPROCESSING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 GASTROENTEROLOGY
    • 8.3.1 INCREASING USE OF ENDOSCOPES FOR DISEASE DIAGNOSIS TO DRIVE MARKET
    • TABLE 27 MEDICAL DEVICE REPROCESSING MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY
    • 8.4.1 REGULATORY INITIATIVES AND COST REDUCTION TO DRIVE MARKET
    • TABLE 28 APPROVED ORTHOPEDIC/ARTHROSCOPIC DEVICES FOR REPROCESSING
    • TABLE 29 MEDICAL DEVICE REPROCESSING MARKET FOR ARTHROSCOPY AND ORTHOPEDIC SURGERY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.5 GYNECOLOGY
    • 8.5.1 INCREASING GYNECOLOGY PROCEDURES TO DRIVE MARKET
    • TABLE 30 MEDICAL DEVICE REPROCESSING MARKET FOR GYNECOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.6 GENERAL SURGERY
    • 8.6.1 LOW-COST GENERAL SURGERY DEVICES TO IMPACT MARKET
    • TABLE 31 MEDICAL DEVICE REPROCESSING MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.7 OTHER APPLICATIONS
    • TABLE 32 MEDICAL DEVICE REPROCESSING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)

9 MEDICAL DEVICE REPROCESSING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 29 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC SNAPSHOT (2021)
    • TABLE 33 MEDICAL DEVICE REPROCESSING MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
    • TABLE 34 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 35 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 36 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 37 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Presence of major players and healthcare cost reduction strategies to drive market
    • FIGURE 31 US: TOTAL NUMBER OF HOSPITALS
    • TABLE 38 US: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 39 US: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 40 US: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Growing geriatric population and increasing chronic diseases to drive market
    • TABLE 41 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 42 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 43 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 44 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 45 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 46 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 47 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Government initiatives and well-established standards to drive market
    • TABLE 48 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 49 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 50 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Increasing hospital admissions to drive market
    • TABLE 51 UK: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 52 UK: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 53 UK: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Growing diagnostic medical device market with rising chronic diseases to propel market
    • TABLE 54 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 55 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 56 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing use of diagnostic devices and government initiatives to drive market
    • TABLE 57 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 58 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 59 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing focus on reducing hospital costs to drive market
    • TABLE 60 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 61 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 63 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 64 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 65 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 32 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
    • TABLE 66 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 69 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.4.1 AUSTRALIA
      • 9.4.1.1 Growing adoption of medical devices for diagnosis and treatment to drive market
    • TABLE 70 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Regulatory reforms and need to reduce hospital costs to drive market
    • TABLE 73 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 74 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 75 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.4.3 CHINA
      • 9.4.3.1 Government initiatives and developing economy to drive market
    • TABLE 76 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 77 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 78 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Government initiatives for diagnosis and treatment to drive market
    • TABLE 79 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 80 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE 2020-2027 (USD MILLION)
    • TABLE 81 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 82 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 83 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 84 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 INCREASING CHRONIC DISEASES AND ADOPTION OF MEDICAL DEVICES TO DRIVE MARKET
    • TABLE 85 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 EMERGENCE OF REGULATORY FRAMEWORKS TO DRIVE MARKET
    • TABLE 88 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 89 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020-2027 (USD MILLION)
    • TABLE 90 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL DEVICE REPROCESSING MARKET
  • 10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
    • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICE REPROCESSING MARKET
  • 10.4 MARKET SHARE ANALYSIS, 2021
    • FIGURE 34 MEDICAL DEVICE REPROCESSING MARKET SHARES, BY KEY PLAYER, 2021
    • TABLE 91 MEDICAL DEVICE REPROCESSING MARKET: DEGREE OF COMPETITION
  • 10.5 COMPETITIVE BENCHMARKING
    • TABLE 92 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF SMALL AND MEDIUM PLAYERS
  • 10.6 COMPANY FOOTPRINT
    • TABLE 93 FOOTPRINT OF COMPANIES IN MEDICAL DEVICE REPROCESSING MARKET
    • TABLE 94 SERVICE FOOTPRINT OF COMPANIES (16 COMPANIES)
    • TABLE 95 APPLICATION FOOTPRINT OF COMPANIES (16 COMPANIES)
    • TABLE 96 REGIONAL FOOTPRINT OF COMPANIES (16 COMPANIES)
  • 10.7 COMPANY EVALUATION QUADRANT
    • 10.7.1 STARS
    • 10.7.2 EMERGING LEADERS
    • 10.7.3 PERVASIVE PLAYERS
    • 10.7.4 PARTICIPANTS
    • FIGURE 35 MEDICAL DEVICE REPROCESSING MARKET: COMPANY EVALUATION QUADRANT (2021)
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 FDA APPROVALS/SERVICE ENHANCEMENTS
    • 10.8.2 DEALS
    • 10.8.3 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 STRYKER CORPORATION
    • TABLE 100 STRYKER CORPORATION: COMPANY OVERVIEW
    • FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2021)
    • 11.1.2 JOHNSON & JOHNSON
    • TABLE 101 JOHNSON & JOHNSON: COMPANY OVERVIEW
    • FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
    • 11.1.3 MEDTRONIC PLC
    • TABLE 102 MEDTRONIC PLC: COMPANY OVERVIEW
    • FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
    • 11.1.4 STERIS HEALTHCARE
    • TABLE 103 STERIS HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 39 STERIS HEALTHCARE: COMPANY SNAPSHOT (2021)
    • 11.1.5 CARDINAL HEALTH (SUSTAINABLE TECHNOLOGIES)
    • TABLE 104 CARDINAL HEALTH: COMPANY OVERVIEW
    • FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
    • 11.1.6 ARJO GROUP (RENU MEDICAL, INC.)
    • TABLE 105 ARJO GROUP: COMPANY OVERVIEW
    • FIGURE 41 ARJO GROUP: COMPANY SNAPSHOT (2021)
    • 11.1.7 VANGUARD AG
    • TABLE 106 VANGUARD AG: COMPANY OVERVIEW
    • 11.1.8 MEDLINE RENEWAL
    • TABLE 107 MEDLINE RENEWAL: COMPANY OVERVIEW
    • 11.1.9 INNOVATIVE HEALTH
    • TABLE 108 INNOVATIVE HEALTH: COMPANY OVERVIEW
    • 11.1.10 STERIPRO CANADA, INC
    • TABLE 109 STERIPRO CANADA, INC.: COMPANY OVERVIEW
    • 11.1.11 NORTHEAST SCIENTIFIC, INC.
    • TABLE 110 NE SCIENTIFIC, INC.: COMPANY OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 SURETEK MEDICAL
    • 11.2.2 KONOIKE GROUP
    • 11.2.3 AVANTE HEALTH SOLUTIONS
    • 11.2.4 MEDSALV
    • 11.2.5 VITRUVIA MEDICAL AG
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 CUSTOMIZATION OPTIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS